Cigna Group Files 8-K Report

TL;DR

Cigna Group filed its 8-K, standard corporate update.

AI Summary

On September 2, 2025, The Cigna Group filed an 8-K report. The filing indicates that the company is incorporated in Delaware and its principal executive offices are located at 900 Cottage Grove Road, Bloomfield, Connecticut. The report does not disclose specific financial transactions or material events beyond its routine filing status.

Why It Matters

This filing confirms routine corporate information for The Cigna Group, which is standard for publicly traded companies and provides transparency to investors.

Risk Assessment

Risk Level: low — This is a routine corporate filing that does not contain new material information or disclose any significant risks.

Key Players & Entities

• The Cigna Group (company) — Registrant
• Delaware (jurisdiction) — State of incorporation
• 900 Cottage Grove Road, Bloomfield, Connecticut (location) — Principal executive offices

FAQ

From the Filing

0001140361-25-033536.txt : 20250902 0001140361-25-033536.hdr.sgml : 20250902 20250902063046 ACCESSION NUMBER: 0001140361-25-033536 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20250902 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20250902 DATE AS OF CHANGE: 20250902 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cigna Group CENTRAL INDEX KEY: 0001739940 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 824991898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38769 FILM NUMBER: 251282878 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Cigna Corp DATE OF NAME CHANGE: 20181221 FORMER COMPANY: FORMER CONFORMED NAME: Halfmoon Parent, Inc. DATE OF NAME CHANGE: 20180508 8-K 1 ef20054926_8k.htm 8-K false 0001739940 NYSE 0001739940 2025-09-02 2025-09-02 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 2, 2025 The Cigna Group (Exact name of registrant as specified in its charter) Delaware 001-38769 82-4991898 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 900 Cottage Grove Road Bloomfield , Connecticut 06002 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: ( 860 ) 226-6000 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $0.01 CI New York Stock Exchange, Inc. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 7.01 Regulation FD Disclosure.   2025 Outlook Affirmation   The Cigna Group (or “our”) officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, The Cigna Group officials expect to reaffirm projected full year 2025 consolidated adjusted income from operations on a per share basis of at least $29.60 per share.   The Cigna Group previously discussed its full year 2025 outlook in its press release dated July 31, 2025, and during the related investor conference call. The press release and the conference call transcript are available in the Investor Relations section of The Cigna Group’s website located at www.thecignagroup.com. Forward-looking statements in these documents and the related call speak only as of the date they were made.   Adjusted